Investors

Press Release


Taylor Schreiber to speak at the 2020 PEGS: The Essential Protein Engineering & Cell Therapy Summit, May 4-8, Boston, MA

February 4, 2020

Shattuck Labs CEO and Co-Founder to give presentation: CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade to Bridge Innate and Adaptive ImmunityFor Agenda and Registration go to https://www.pegsummit.com/Immunotherapy-Targets